Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2007 1
2011 1
2012 1
2013 5
2014 5
2015 12
2016 10
2017 8
2018 13
2019 4
2020 4
2021 6
2022 5
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ; ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Davis ID, et al. N Engl J Med. 2019 Jul 11;381(2):121-131. doi: 10.1056/NEJMoa1903835. Epub 2019 Jun 2. N Engl J Med. 2019. PMID: 31157964 Clinical Trial.
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Sweeney CJ, Martin AJ, Stockler MR, Begbie S, Cheung L, Chi KN, Chowdhury S, Frydenberg M, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Vera-Badillo F, Williams SG, Winter D, Yip S, Zhang AY, Zielinski RR, Davis ID; ENZAMET trial investigators and Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Sweeney CJ, et al. Lancet Oncol. 2023 Apr;24(4):323-334. doi: 10.1016/S1470-2045(23)00063-3. Lancet Oncol. 2023. PMID: 36990608 Clinical Trial.
Biocatalysts from alkaloid producing plants.
Kries H, O'Connor SE. Kries H, et al. Curr Opin Chem Biol. 2016 Apr;31:22-30. doi: 10.1016/j.cbpa.2015.12.006. Epub 2016 Jan 13. Curr Opin Chem Biol. 2016. PMID: 26773811 Free article. Review.
Engineering of Secondary Metabolism.
O'Connor SE. O'Connor SE. Annu Rev Genet. 2015;49:71-94. doi: 10.1146/annurev-genet-120213-092053. Epub 2015 Sep 21. Annu Rev Genet. 2015. PMID: 26393965 Review.
Biosynthesis of the ergot alkaloids.
Jakubczyk D, Cheng JZ, O'Connor SE. Jakubczyk D, et al. Nat Prod Rep. 2014 Oct;31(10):1328-38. doi: 10.1039/c4np00062e. Nat Prod Rep. 2014. PMID: 25164781 Review.
Inflammation and cancer stem cells.
Shigdar S, Li Y, Bhattacharya S, O'Connor M, Pu C, Lin J, Wang T, Xiang D, Kong L, Wei MQ, Zhu Y, Zhou S, Duan W. Shigdar S, et al. Cancer Lett. 2014 Apr 10;345(2):271-8. doi: 10.1016/j.canlet.2013.07.031. Epub 2013 Aug 11. Cancer Lett. 2014. PMID: 23941828 Review.
New developments in engineering plant metabolic pathways.
Tatsis EC, O'Connor SE. Tatsis EC, et al. Curr Opin Biotechnol. 2016 Dec;42:126-132. doi: 10.1016/j.copbio.2016.04.012. Epub 2016 Apr 29. Curr Opin Biotechnol. 2016. PMID: 27132124 Free article. Review.
Clinical development of new drug-radiotherapy combinations.
Sharma RA, Plummer R, Stock JK, Greenhalgh TA, Ataman O, Kelly S, Clay R, Adams RA, Baird RD, Billingham L, Brown SR, Buckland S, Bulbeck H, Chalmers AJ, Clack G, Cranston AN, Damstrup L, Ferraldeschi R, Forster MD, Golec J, Hagan RM, Hall E, Hanauske AR, Harrington KJ, Haswell T, Hawkins MA, Illidge T, Jones H, Kennedy AS, McDonald F, Melcher T, O'Connor JP, Pollard JR, Saunders MP, Sebag-Montefiore D, Smitt M, Staffurth J, Stratford IJ, Wedge SR; NCRI CTRad Academia-Pharma Joint Working Group. Sharma RA, et al. Nat Rev Clin Oncol. 2016 Oct;13(10):627-42. doi: 10.1038/nrclinonc.2016.79. Epub 2016 Jun 1. Nat Rev Clin Oncol. 2016. PMID: 27245279 Free article.
75 results